Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
824 Leser
Artikel bewerten:
(2)

Ceva Santé Animale launches the 2024 edition of its "Call for Projects" to help advance the human-animal bond

LIBOURNE, France, Sept. 18, 2023 /PRNewswire/ -- After the success of its first European edition last year, Ceva Santé Animale (Ceva), the #5 global animal health company, present in 110 countries worldwide, is pleased to announce the launch of its highly anticipated 2024 "Call for Projects". This worldwide event aims to discover and support new, innovative solutions for the well-being and care of companion animals and their pet parents.

Ceva Santé Animale Timeline Call For Projects

With a deep commitment and a recognized expertise to improving the lives of companion animals, Ceva knows the important role pets play in our lives and is dedicated to continuing to advance Human-Animal bond, a central piece of the company's One Health approach.

Through the "Call for Projects" program, the company seeks to harness the expertise and creativity of individuals, startups, and organizations to address key issues in animal health and develop groundbreaking solutions that will benefit companion animals worldwide.

The challenge welcomes projects that span a wide range of areas, including but not limited to:

  • Digital Health Solutions: leveraging technology and data to enhance the monitoring, diagnosis, and treatment of companion animals.
  • Preventive Care: novel approaches to preventive care, such as nutrition, vaccination, and behavior management.
  • Wellness and Enrichment: innovative products or services that promote physical and mental well-being in companion animals.
  • Diagnostic Tools: advanced diagnostic tools, including rapid and non-invasive methods for accurate diagnosis and monitoring of animal health.

Objectives are to co-develop innovations to advance pet well-being and support the human-animal bond.

Participants are encouraged to submit their project proposals, detailing their innovative solutions, target audience, and potential impact on Agorize. Projects must be submitted in one (or more) of the categories available on the platform: Devices, Digital or Technology.

A panel of judges, comprising leading experts from Ceva, will carefully evaluate the submissions based on criteria such as innovation, feasibility, scalability, and potential for impact.

Selected projects will receive valuable support from Ceva, including mentorship, access to industry networks, and resources to accelerate the development and commercialization of their innovative solutions. Additionally, the selected projects will gain recognition and visibility within the animal health community, paving the way for future collaborations and partnerships.

We are excited to launch the 2024 'Call for Projects'" said Marc Prikazsky, Chairman and CEO at Ceva. "Companion animals play an essential role in our lives, and we are convinced that by fostering innovation, we can improve their well-being and ensure they receive the care they deserve. With the increasing humanization of pets, our furry companions have become a member of the family. "Pet parents" are increasingly looking for new solutions to provide them with the best possible care. That's why we encourage individuals and organizations from diverse backgrounds to participate and help us discover game-changing solutions for companion animal health."

For more information and to submit a project, please visit: Ceva Open Innovation Hub - Ceva

About Ceva Santé Animale
Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers.

With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: "Together, beyond animal health".

2022 turnover: €1.5 billion.

https://www.ceva.com/

Logo - https://mma.prnewswire.com/media/2014922/Ceva_Sant_Animale_Logo.jpg
Photo - https://mma.prnewswire.com/media/2212416/Ceva_Sant_Animale_Timeline.jpg
Photo - https://mma.prnewswire.com/media/2212417/Ceva_Sant_Animale_Call.jpg

Contact: Emilie Barrail, Head of external communication / emilie.barrail@ceva.com

Ceva Santé Animale Call For Projects

Ceva Santé Animale Logo (PRNewsfoto/Ceva Santé Animale)

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ceva-sante-animale-launches-the-2024-edition-of-its-call-for-projects-to-help-advance-the-human-animal-bond-301929445.html

© 2023 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.